Microbot Medical has expressed support for a new American Medical Association (AMA) policy adopted in late 2025 to strengthen occupational radiation protections for healthcare professionals and trainees.
The policy focuses on the need for continued research into the health effects of cumulative exposure to ionizing radiation, the effectiveness of personal protection equipment (PPE), and education and training to minimize occupational risk to physicians and to their patients.
Microbot cited its Liberty Endovascular Robotic System as a tool for reducing radiation exposure in interventional procedures.
The Liberty system is remotely operated, allowing physicians to perform peripheral endovascular procedures away from the radiation source, according to the company. In the ACCESS-PVI study, use of the system was associated with a 92% relative reduction in radiation exposure, Microbot said. The company noted that radiation exposure has been cited as a factor contributing to staffing shortages in interventional radiology.
Liberty received clearance from the U.S. Food and Drug Administration as a single-use, remotely operated robotic system for peripheral endovascular procedures. Microbot began a limited market release in late 2025 and plans a full market release at the Society of Interventional Radiology (SIR) annual meeting in April 2026, the firm said.
